HALOZYME THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Capex↓-53.2% -$2M
$1M
Acquisitions
$726M
Stock Buybacks↓-100.0% -$250M
$0
Debt Issued
—
Debt Repaid
—